Lv679
2270 积分 2024-04-28 加入
Total Synthesis of Enlicitide Decanoate
2天前
已完结
MYC in cancer: from undruggable target to clinical trials
18天前
已完结
Redox-neutral organocatalytic Mitsunobu reactions
20天前
已完结
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
4个月前
已完结
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
4个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
5个月前
已完结
Core Modifications of GSK3335103 toward Orally Bioavailable αvβ6 Inhibitors with Improved Synthetic Tractability
5个月前
已完结
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
5个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
5个月前
已完结
皖公网安备34019202002308
